Ki-67 expression and residual tumour (R) classification are associated with disease-free survival in desmoid tumour patients

Anticancer Research

Volumn 21, Issue 5, 2001, Pages 3615-3620

  Brueckl, Wolfgang M ^a   Preuss, Judith M M ^a   Wein, Axel ^a   Jung, Andreas ^a   Brabletz, Thomas ^a   Pflüger, Rafael ^a   Wiest, Gunther H ^a   Wölfl, Christoph ^a   Kirchner, Thomas ^a   Hahn, Eckhart G ^a   Hohenberger, Werner ^a   Günther, Klaus ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Aggressive fibromatosis; Desmoid tumour; Disease free survival; Familial adenomatous polyposis (FAP); Immunohistochemistry; Ki 67; Prognosis; Residual tumour (R) classification

Indexed keywords

KI 67 ANTIGEN; SULINDAC; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER SURVIVAL; DESMOID TUMOR; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADENOMATOUS POLYPOSIS COLI; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; FIBROMATOSIS, AGGRESSIVE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0035568891     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder
2. Surgical management of intra-abdominal desmoid tumours
3. A desmoid tumor of the pancreas. Sporadic intra-abdominal desmoids revisited
4. The desmoid tumor. II. Analysis of factors possibly contributing to the etiology and growth behavior
5. The desmoid tumor. III. A biochemical and genetic analysis
6. Gardner's syndrome, review of the literature and report on a family
7. Desmoid tumors in patients with familial adenomatous polyposis
8. The spectrum of polyposis
9. Causes of death and postsurgical survival in familial adenomatous polyposis: Results from the Italian Registry of Familial Polyposis Writing Committee
10. The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population
11. The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor
12. Recent trends in the management of desmoid tumors. Summary of 19 cases and review of the literature
13. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
14. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas
15. Clinicopathological and interphase cytogenetic analysis of desmoid tumours
16. An aggressive desmoid tumor in a patient with familial adenomatous polyposis: Immunohistochemical findings
17. The enigma of desmoid tumors
18. Desmoid tumours complicating familial adenomatous polyposis
19. Aggressive fibromatosis (non-familial desmoid tumour): Therapeutic problems and the role of adjuvant radiotherapy
20. Desmoid tumors and their management
21. The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis
22. Indomethacin and ascorbate inhibit desmoid tumors
23. The role of radiotherapy in the treatment of desmoid tumours
24. Desmoid tumors in adults: The role of radiotherapy in their management
25. Desmoid disease in patients with familial adenomatous polyposis
26. Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis
27. Mesenteric desmoid tumor in Gardner's syndrome treated by sulindac
28. Extra-abdominal desmoid tumors
29. The desmoid tumor. Not a benign disease
30. Intra-abdominal fibromatosis. A pathologic analysis of 130 tumors with comparison of clinical subgroups
31. Desmoid tumours of the anterior abdominal wall